Joseph Patrick Nkolola, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
AIDS Vaccines | 17 | 2023 | 900 | 2.130 |
Why?
|
Antibodies, Neutralizing | 29 | 2024 | 2011 | 1.940 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 11 | 2020 | 381 | 1.650 |
Why?
|
Simian immunodeficiency virus | 16 | 2022 | 814 | 1.640 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 15 | 2022 | 545 | 1.640 |
Why?
|
Macaca mulatta | 28 | 2024 | 2363 | 1.500 |
Why?
|
HIV-1 | 28 | 2024 | 6961 | 1.470 |
Why?
|
HIV Antibodies | 17 | 2024 | 1341 | 1.460 |
Why?
|
Antibodies, Viral | 18 | 2024 | 3216 | 1.390 |
Why?
|
Viral Vaccines | 7 | 2022 | 596 | 1.220 |
Why?
|
HIV Seropositivity | 2 | 2023 | 966 | 0.730 |
Why?
|
Antibodies, Monoclonal | 10 | 2024 | 9263 | 0.590 |
Why?
|
Immunity, Cellular | 12 | 2021 | 1561 | 0.590 |
Why?
|
HIV Infections | 18 | 2024 | 17569 | 0.590 |
Why?
|
Adjuvants, Immunologic | 4 | 2020 | 998 | 0.470 |
Why?
|
SAIDS Vaccines | 4 | 2020 | 144 | 0.430 |
Why?
|
Neutralization Tests | 6 | 2024 | 739 | 0.420 |
Why?
|
Vaccinia virus | 4 | 2018 | 328 | 0.420 |
Why?
|
Immunity, Humoral | 10 | 2021 | 610 | 0.410 |
Why?
|
Guinea Pigs | 7 | 2019 | 1310 | 0.390 |
Why?
|
Toll-Like Receptor 7 | 4 | 2022 | 169 | 0.360 |
Why?
|
Vaccines, DNA | 4 | 2020 | 279 | 0.350 |
Why?
|
Viral Load | 12 | 2024 | 3396 | 0.350 |
Why?
|
Anti-Retroviral Agents | 6 | 2022 | 1789 | 0.340 |
Why?
|
Gene Products, env | 4 | 2020 | 250 | 0.320 |
Why?
|
Immunization, Passive | 4 | 2022 | 619 | 0.320 |
Why?
|
Vaccination | 8 | 2023 | 3437 | 0.240 |
Why?
|
Nucleocapsid | 1 | 2024 | 61 | 0.230 |
Why?
|
Macaca | 2 | 2022 | 413 | 0.230 |
Why?
|
Animals | 39 | 2024 | 169246 | 0.220 |
Why?
|
Vero Cells | 1 | 2024 | 486 | 0.220 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2018 | 2204 | 0.220 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3115 | 0.200 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3238 | 0.200 |
Why?
|
Vaccines, Inactivated | 2 | 2020 | 186 | 0.200 |
Why?
|
Adenoviridae | 4 | 2018 | 1092 | 0.180 |
Why?
|
Antiviral Agents | 3 | 2022 | 3073 | 0.170 |
Why?
|
Integrin alpha4 | 1 | 2019 | 88 | 0.160 |
Why?
|
Integrin beta Chains | 1 | 2019 | 115 | 0.160 |
Why?
|
Capsid | 1 | 2021 | 435 | 0.160 |
Why?
|
Epitopes | 3 | 2019 | 2528 | 0.160 |
Why?
|
Capsid Proteins | 1 | 2021 | 468 | 0.150 |
Why?
|
Antibody Formation | 3 | 2020 | 1393 | 0.140 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2004 | 1801 | 0.140 |
Why?
|
Pandemics | 4 | 2020 | 8748 | 0.140 |
Why?
|
HIV Envelope Protein gp120 | 3 | 2021 | 925 | 0.140 |
Why?
|
Milk, Human | 1 | 2021 | 490 | 0.130 |
Why?
|
Thrombocytopenia | 1 | 2023 | 1179 | 0.130 |
Why?
|
Female | 31 | 2024 | 397192 | 0.120 |
Why?
|
Immunization, Secondary | 4 | 2020 | 373 | 0.120 |
Why?
|
Dengue | 1 | 2018 | 258 | 0.120 |
Why?
|
RNA, Viral | 2 | 2021 | 2872 | 0.120 |
Why?
|
Immunization | 3 | 2019 | 1219 | 0.120 |
Why?
|
Germinal Center | 1 | 2017 | 380 | 0.120 |
Why?
|
Fetal Blood | 1 | 2021 | 1361 | 0.110 |
Why?
|
DNA, Viral | 5 | 2021 | 2204 | 0.110 |
Why?
|
Bronchoalveolar Lavage Fluid | 3 | 2021 | 760 | 0.110 |
Why?
|
T-Lymphocytes | 4 | 2024 | 10266 | 0.100 |
Why?
|
Amino Acid Sequence | 5 | 2019 | 13421 | 0.100 |
Why?
|
Drug Discovery | 1 | 2020 | 1068 | 0.100 |
Why?
|
Virus Replication | 4 | 2021 | 2458 | 0.100 |
Why?
|
Viruses | 1 | 2016 | 373 | 0.100 |
Why?
|
Protein Stability | 1 | 2014 | 580 | 0.100 |
Why?
|
Humans | 32 | 2024 | 768166 | 0.100 |
Why?
|
Protein Multimerization | 2 | 2017 | 965 | 0.090 |
Why?
|
Double-Blind Method | 6 | 2021 | 12465 | 0.090 |
Why?
|
Placebos | 3 | 2021 | 1667 | 0.090 |
Why?
|
HIV | 1 | 2018 | 1597 | 0.090 |
Why?
|
Cross Reactions | 3 | 2021 | 828 | 0.090 |
Why?
|
Genetic Vectors | 5 | 2018 | 3402 | 0.090 |
Why?
|
Viremia | 3 | 2022 | 726 | 0.090 |
Why?
|
Vaccines | 1 | 2019 | 842 | 0.090 |
Why?
|
Adoptive Transfer | 3 | 2018 | 825 | 0.090 |
Why?
|
Thrombosis | 1 | 2023 | 2957 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2021 | 3474 | 0.080 |
Why?
|
Cytokines | 1 | 2024 | 7453 | 0.080 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14729 | 0.080 |
Why?
|
Antigens, Viral | 2 | 2018 | 995 | 0.080 |
Why?
|
Immunization Schedule | 2 | 2020 | 228 | 0.080 |
Why?
|
Gene Products, pol | 2 | 2020 | 43 | 0.080 |
Why?
|
Epitopes, B-Lymphocyte | 2 | 2020 | 85 | 0.080 |
Why?
|
Adult | 14 | 2024 | 223646 | 0.070 |
Why?
|
Research Design | 1 | 2023 | 6211 | 0.070 |
Why?
|
Gene Products, gag | 2 | 2020 | 318 | 0.070 |
Why?
|
Inhibitory Concentration 50 | 2 | 2019 | 464 | 0.070 |
Why?
|
Vaccines, Synthetic | 2 | 2021 | 622 | 0.070 |
Why?
|
Middle Aged | 13 | 2024 | 223492 | 0.070 |
Why?
|
Male | 19 | 2024 | 364719 | 0.070 |
Why?
|
Vaccines, Subunit | 2 | 2018 | 159 | 0.070 |
Why?
|
Nasal Mucosa | 2 | 2020 | 416 | 0.070 |
Why?
|
Immunoglobulin G | 4 | 2022 | 4568 | 0.070 |
Why?
|
Disease Models, Animal | 6 | 2021 | 18349 | 0.070 |
Why?
|
Young Adult | 10 | 2021 | 60066 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3814 | 0.070 |
Why?
|
Protein Binding | 2 | 2019 | 9343 | 0.070 |
Why?
|
Immunologic Memory | 3 | 2020 | 1377 | 0.060 |
Why?
|
Mice | 5 | 2024 | 82029 | 0.060 |
Why?
|
Bacteria | 1 | 2016 | 2216 | 0.060 |
Why?
|
Molecular Sequence Data | 2 | 2010 | 17622 | 0.060 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6514 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2021 | 4648 | 0.060 |
Why?
|
Antibody Specificity | 2 | 2016 | 1065 | 0.050 |
Why?
|
Mice, Inbred BALB C | 2 | 2018 | 6231 | 0.050 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 1730 | 0.050 |
Why?
|
Viral Envelope Proteins | 2 | 2016 | 640 | 0.050 |
Why?
|
Transduction, Genetic | 1 | 2004 | 899 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2021 | 4415 | 0.050 |
Why?
|
Limit of Detection | 1 | 2021 | 277 | 0.040 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 112 | 0.040 |
Why?
|
Lymphoid Tissue | 1 | 2021 | 445 | 0.040 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2019 | 151 | 0.040 |
Why?
|
Thailand | 1 | 2020 | 288 | 0.040 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 136 | 0.040 |
Why?
|
Codon, Terminator | 1 | 2019 | 125 | 0.040 |
Why?
|
Binding, Competitive | 1 | 2020 | 1142 | 0.040 |
Why?
|
Lactation | 1 | 2021 | 392 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 325 | 0.040 |
Why?
|
Pteridines | 1 | 2018 | 47 | 0.040 |
Why?
|
Injections, Intramuscular | 1 | 2020 | 556 | 0.040 |
Why?
|
Genetic Engineering | 1 | 2004 | 936 | 0.040 |
Why?
|
Cell Line | 2 | 2020 | 15597 | 0.040 |
Why?
|
Mutant Proteins | 1 | 2020 | 488 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 1 | 2024 | 2596 | 0.040 |
Why?
|
Microspheres | 1 | 2021 | 788 | 0.040 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 454 | 0.040 |
Why?
|
Immunoassay | 1 | 2021 | 746 | 0.040 |
Why?
|
Peptide Fragments | 2 | 2021 | 5151 | 0.040 |
Why?
|
Nose | 1 | 2021 | 522 | 0.040 |
Why?
|
Drug Substitution | 1 | 2020 | 291 | 0.040 |
Why?
|
Syndrome | 1 | 2023 | 3272 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2018 | 14783 | 0.030 |
Why?
|
Blotting, Western | 1 | 2004 | 5027 | 0.030 |
Why?
|
Aspartate Aminotransferases | 1 | 2018 | 414 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2004 | 3160 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2017 | 687 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2020 | 620 | 0.030 |
Why?
|
Immunity, Innate | 2 | 2018 | 3080 | 0.030 |
Why?
|
Dizziness | 1 | 2018 | 269 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2015 | 1361 | 0.030 |
Why?
|
Primates | 1 | 2017 | 520 | 0.030 |
Why?
|
Back Pain | 1 | 2018 | 548 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2021 | 1854 | 0.030 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2014 | 361 | 0.030 |
Why?
|
Drug Carriers | 1 | 2018 | 709 | 0.030 |
Why?
|
Phylogeny | 1 | 2021 | 2843 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2020 | 19015 | 0.030 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1354 | 0.030 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2021 | 1903 | 0.030 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2014 | 306 | 0.030 |
Why?
|
Maternal Exposure | 1 | 2020 | 1096 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2040 | 0.030 |
Why?
|
Ultracentrifugation | 1 | 2012 | 182 | 0.020 |
Why?
|
Microcephaly | 1 | 2016 | 426 | 0.020 |
Why?
|
Brazil | 1 | 2016 | 1250 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2018 | 1070 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 2012 | 636 | 0.020 |
Why?
|
Aged | 1 | 2024 | 171504 | 0.020 |
Why?
|
Adolescent | 4 | 2021 | 89169 | 0.020 |
Why?
|
Diarrhea | 1 | 2018 | 1320 | 0.020 |
Why?
|
Surface Plasmon Resonance | 1 | 2012 | 272 | 0.020 |
Why?
|
Lung Diseases, Interstitial | 1 | 2020 | 940 | 0.020 |
Why?
|
Fatigue | 1 | 2018 | 1557 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3912 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4283 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7243 | 0.020 |
Why?
|
Pregnancy | 2 | 2021 | 30256 | 0.020 |
Why?
|
Models, Molecular | 1 | 2019 | 5403 | 0.020 |
Why?
|
Gene Deletion | 1 | 2016 | 2675 | 0.020 |
Why?
|
Computational Biology | 1 | 2020 | 3568 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8509 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2016 | 1206 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2020 | 65371 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 40218 | 0.020 |
Why?
|
Base Sequence | 1 | 2017 | 12421 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10760 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 54926 | 0.020 |
Why?
|
Immunodominant Epitopes | 1 | 2006 | 244 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2020 | 12800 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 505 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3711 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20227 | 0.010 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2006 | 827 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2018 | 4573 | 0.010 |
Why?
|
Lung | 1 | 2020 | 10099 | 0.010 |
Why?
|
Genetic Variation | 1 | 2016 | 6611 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41754 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2006 | 5902 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 30238 | 0.010 |
Why?
|